Yi-Hsuan Chu

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “The third-generation EGFR inhibitor almonertinib (HS-10296) resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs”.

The third-generation EGFR inhibitor almonertinib (HS-10296) resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs

Biochemical Pharmacology(2021)10.1016/j.bcp.2021.114516

N/A

0DataRank · unranked

40 citations

Tai‐Ho Hung, Sabrina Lusvarghi, Yi-Hsuan Chu, Sung-Han Hsiao, Yang-Hui Huang +3 more

ABCG2 Mediates Resistance to the Dual EGFR and PI3K Inhibitor MTX-211 in Cancer Cells

International Journal of Molecular Sciences(2024)10.3390/ijms25105160

N/A

0DataRank · unranked

1 citations

Cheng‐Yu Hung, Megumi Murakami, Yu‐Shan Wu, Yi-Hsuan Chu, Yang-Hui Huang +3 more